Herstellung von Sitagliptin: ein Paradebeispiel für die Prozessoptimierung
Author:
- 31 January 2011
- journal article
- highlight
- Published by Wiley in Angewandte Chemie
- Vol. 123 (9) , 2018-2020
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Direct Asymmetric Reductive AminationJournal of the American Chemical Society, 2009
- Clinical Application of Incretin-Based Therapy: Therapeutic Potential, Patient Selection and Clinical UseEuropean Journal of Internal Medicine, 2009
- Highly Efficient Asymmetric Synthesis of SitagliptinJournal of the American Chemical Society, 2009
- Safety and tolerability of sitagliptin in patients with type 2 diabetes: a pooled analysisBMC Endocrine Disorders, 2008
- Dipeptidyl Peptidase-4 Inhibitors for the Treatment of Type 2 Diabetes: Focus On SitagliptinClinical Pharmacology & Therapeutics, 2007
- Identification of Ammonium Chloride as an Effective Promoter of the Asymmetric Hydrogenation of a β-Enamine AmideOrganic Process Research & Development, 2006
- First Generation Process for the Preparation of the DPP-IV Inhibitor SitagliptinOrganic Process Research & Development, 2005
- (2R)-4-Oxo-4-[3-(Trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin- 7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine: A Potent, Orally Active Dipeptidyl Peptidase IV Inhibitor for the Treatment of Type 2 DiabetesJournal of Medicinal Chemistry, 2004
- Mechanistic Evidence for an α-Oxoketene Pathway in the Formation of β-Ketoamides/Esters via Meldrum's Acid AdductsJournal of the American Chemical Society, 2004
- Highly Efficient Synthesis of β-Amino Acid Derivatives via Asymmetric Hydrogenation of Unprotected EnaminesJournal of the American Chemical Society, 2004